In: neurodegenerative disorders
28 Apr, 2021Tech Snapshot® – Targeting Neuroinflammation to Combat Neurodegenerative and Rare Diseases
Tech Snapshot® captures today’s cutting-edge tools and technologies that will help drive drug discovery tomorrow. This installment was written by QPS, a global leader in clinical and preclinical research.Read More
We have seen a recent interest for Caenorhabditis elegans (C. elegans) research services and wanted to share with our users exactly how useful this little worm in pharmaceutical research is turning out to be the study of Parkinson’s Disease (PD) has led to the development of many pharmacological models from transgenic rodents to non-human primates, and now worms (the aforementioned C. elegans, to be exact).
Many researchers have taken advantage of this tiny, transparent worm to study PD as well as Alzheimer’s disease, cystic fibrosis, ALS, epilepsy, and dystonia. The worm possesses a nervous system, digestive tract, musculature and reproductive system, which are all clearly visible with the use of fluorescent proteins inserted through genetic engineering.Read More